Searched for
PARAS PHARMACEUTICALS
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...- Drug companies directed to step up vigil on adverse reactionsIndia's drug regulator, CDSCO, has mandated all drug companies to establish systems for tracking adverse drug reactions. This move comes am...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- Vini Cosmetics in talks with Apax, TA Associates & Advent to sell minority stakeVini Cosmetics, started by Darshan Patel, who was among the family promoters of Paras Pharmaceuticals, manufactures personal care, pharmace...
- Vini Cosmetics promoter Darshan Patel plans to raise Rs 400 crore to fund buyoutsPatel is one of the three brothers who managed Paras Pharmaceuticals that had OTC brands like Itch-Guard, Krack, Moov and personal care bra...
- Ex-Paras Pharmaceuticals executives launch cosmeceutical startupThree former top executives of Paras Pharmaceuticals, the Ahmedabad company that owned brands such as Moov, Itch Guard and Dermicool, are b...
- Private equity fund Sequoia may invest Rs 100 crore in Vini CosmeticsDarshan Patel is back in the market to raise money for his personal care company Vini Cosmetics.
- Eyeing to buy Paras' personal care: EmamiEmami on Sunday said it is in talks with global FMCG giant Reckitt Benckiser to buy the personal care business of Paras Healthcare.
- Reckitt to absorb top Paras executivesReckitt Benckiser would absorb top 10 executives of Paras Pharmaceuticals and retain 200 people working at its Baddi plant in an in-princip...
- Paras fought a dozen copyright cases every yearSince the days of its first successful product Stopache in the ‘80s, Paras Pharmaceuticals has seen copycats aping its flagship brands.
- From Paras to PE fund, Patel on the MoovBarely two days after he sold off Paras Pharmaceuticals, Girish Patel is back to what he does best—building enterprise.
- Reckitt Benckiser to buy Paras Pharmaceuticals for Rs 3,260 croreBritish consumer goods firm Reckitt Benckiser Group, confirmed it will buy Ahmedabad-based Paras Pharmaceuticals for 3,260 crore ($726 mill...
- Reckitt Benckiser may snap up Paras PharmaA leading UK-based company is all set to buy Ahmedabad-based Paras Pharmaceuticals, a person close to the development said.
- Darshan Patel targets Paras Pharmaceuticals brandsDarshan Patel, the estranged brother of Paras Pharmaceuticals CMD Girish Patel, is set to take on brands such as DermiCool, ItchGuard and B...
- Emami gets board nod to raise Rs 5,000 crThe board of Emami group has approved a plan to raise up to Rs 5,000 crore through debt and equity dilution.
- Japan's Taisho leads race for Paras PharmaTaisho Pharmaceuticals has emerged as the front-runner to buy a majority stake in Paras Pharmaceuticals by offering over six times the annu...
- Rivals may join hands for Paras buySome rival potential suitors of Ahmedabad-based Paras Pharmaceuticals are considering the option of co-bidding for the Rs 500-crore company...
- Sequoia invests $12 mn in Paras PharmaLeading venture capital and growth equity investor Sequoia Capital India has invested $12 million in Ahmedabad-based over-the-counter (OTC)...
- Actis to buy 10% in Paras for Rs 100 crPrivate equity major Actis is close to picking up 10% in the Ahmedabad-based Paras Pharmaceuticals, the company that owns well known brands...
Load More
